Neuro-Oncology

Neuro-Oncology Advances

Neuro-Oncology Practice

Prognosis of intracranial meningiomas with TERTp mutation: systematic review with meta-analysis Get access

• Abstract
• Lay summary
• Supplementary data

Graphical Abstract

Graphical Abstract

Leisure-related cognitive reserve and postoperative cognitive outcomes after brain tumor surgery

• Abstracts
• Lay summary
• Supplementary data

Outcomes of Target Therapies for Paediatric BRAF V600-Mutant Low-Grade Gliomas: A systematic review and Meta-Analysis of Clinical and Observational Studies

• Abstract
• Supplementary data

Immunogenomic Profiling Reveals Targets for Gene Therapy in Pediatric Brain Tumors

• Abstract
• Supplementary data

Prognostic impact of PTEN status in recurrent IDH-wildtype glioblastoma receiving second-line therapy

• Abstract
• Supplementary data

An Integrated Transcriptional and Post-Transcriptional Regulatory Circuit Orchestrated by NUDT21 Maintains the Proliferation and Survival of Neuroblastoma

• Abstracts
• Lay summary
• Supplementary data

The prognostic value of CDKN2A/CDKN2B hemizygous deletion in meningioma remains uncertain Get access

Methodological considerations in the assessment of hemizygous CDKN2A/B deletions in meningioma and IDH-mutant glioma Get access

Intracerebroventricular B7-H3-targeting CAR T cells for non-pontine DMG and recurrent/refractory pediatric CNS tumors: a phase 1 trial Get access

• Abstract
• Lay summary
• Supplementary data

APOE and the aging brain after pediatric radiotherapy Get access

• Extract

“Deep Learning-Based Detection of Pediatric Brain Tumor Presence on MRI”

• Abstract
• Lay summary
• Supplementary data

ASL-based Exchange Time Mapping for Differentiation of High-Grade Glioma and Brain Metastases

• Abstract
• Supplementary data

Real-World Disparities in Molecular Diagnosis of Diffuse Gliomas in Brazil: Insights from LACOG 0619 Get access

• Abstract
• Lay summary
• Supplementary data

Tumor Treating Fields Plus Temozolomide Maintenance After Radiochemotherapy in Chinese Grade 4 Gliomas: Efficacy and Predictive Biomarkers

• Abstract
• Supplementary data

Cognitive and Clinical Factors Predicting Return to Work After IDH-mutant Glioma Surgery: Why Clinicians Should Closely Examine Verbal Fluency Scores

• Abstract
• Lay summary
• Supplementary data